PRISM MEDICO AND PHARMACY LTD. - 512217 - Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (LODR) Regulations, 2015 please find enclosed herewith details of related party transactions for the half year ended 31st March, 2024. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 29th May, 2024) which commenced at 04:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve - Consider, approve and take on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 03rd May, 2024) which commenced at 01:00 P.M. and concluded at 01:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company for the financial year 2023-2024. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, Please find the attached outcome of Board Meeting held today i.e. 03rd May, 2024 which commenced at 01:00 P.M. and concluded at 01:30 P.M. Kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Compliance Certificate Certifying The Maintenance Of Physical And Electronic Share Transfer Facility As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2024.
Dear Sir/Madam, Please find the attached certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024.
Dear Sir/Madam, Please find the attached certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2024 for the financial year ended 31st March, 2024. You are requested to take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.
Dear Sir/Madam, Please find the attached confirmation certificate regarding non-applicability of large corporate entity framework. You are requested to take the same on record and acknowledge the receipt. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.
Dear Sir/Madam, With reference to the captioned subject, please find the attached undertaking of functional website. You are requested to kindly take the same on record and oblige. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Dear Sir/Madam, With reference to the captioned subject please find the attached report on investor complaints for the quarter ended 31st March, 2024. You are requested to kindly take the same on record and oblige. Thanking You.